Search

Cardiac Echo, Enzymes Predict Cardiopathy After Breast Cancer Chemo

Cardiac Echo, Enzymes Predict Cardiopathy After Breast Cancer Chemo


After cardiotoxic therapy for breast cancer, two factors help identify women at particular risk, researchers say.
The two markers -- cardiac troponin and longitudinal strain on echocardiography -- helped show which women were most likely to have cardiotoxicity within 6 months after anthracycline or trastuzumab treatment for breast cancer, in a study reported online March 2nd in the American Journal of Cardiology....